Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1997 Nov 3;16(21):6355–6363. doi: 10.1093/emboj/16.21.6355

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

A Zhou 1, J Paranjape 1, T L Brown 1, H Nie 1, S Naik 1, B Dong 1, A Chang 1, B Trapp 1, R Fairchild 1, C Colmenares 1, R H Silverman 1
PMCID: PMC1170242  PMID: 9351818

Abstract

2',5'-Oligoadenylate-dependent RNase L functions in the interferon-inducible, RNA decay pathway known as the 2-5A system. To determine the physiological roles of the 2-5A system, mice were generated with a targeted disruption of the RNase L gene. The antiviral effect of interferon alpha was impaired in RNase L-/- mice providing the first evidence that the 2-5A system functions as an antiviral pathway in animals. In addition, remarkably enlarged thymuses in the RNase L-/- mice resulted from a suppression of apoptosis. There was a 2-fold decrease in apoptosis in vivo in the thymuses and spleens of RNase L-/- mice. Furthermore, apoptosis was substantially suppressed in RNase L-/- thymocytes and fibroblasts treated with different apoptotic agents. These results suggest that both interferon action and apoptosis can be controlled at the level of RNA stability by RNase L. Another implication is that the 2-5A system is likely to contribute to the antiviral activity of interferon by inducing apoptosis of infected cells.

Full Text

The Full Text of this article is available as a PDF (536.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaschke A. J., Staley K., Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development. 1996 Apr;122(4):1165–1174. doi: 10.1242/dev.122.4.1165. [DOI] [PubMed] [Google Scholar]
  2. Brunner T., Mogil R. J., LaFace D., Yoo N. J., Mahboubi A., Echeverri F., Martin S. J., Force W. R., Lynch D. H., Ware C. F. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 1995 Feb 2;373(6513):441–444. doi: 10.1038/373441a0. [DOI] [PubMed] [Google Scholar]
  3. Cayley P. J., Davies J. A., McCullagh K. G., Kerr I. M. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. Eur J Biochem. 1984 Aug 15;143(1):165–174. doi: 10.1111/j.1432-1033.1984.tb08355.x. [DOI] [PubMed] [Google Scholar]
  4. Cayley P. J., Knight M., Kerr I. M. Virus-mediated inhibition of the ppp(A2'p)nA system and its prevention by interferon. Biochem Biophys Res Commun. 1982 Jan 29;104(2):376–382. doi: 10.1016/0006-291x(82)90647-7. [DOI] [PubMed] [Google Scholar]
  5. Chebath J., Benech P., Hovanessian A., Galabru J., Revel M. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem. 1987 Mar 15;262(8):3852–3857. [PubMed] [Google Scholar]
  6. Chebath J., Benech P., Revel M., Vigneron M. Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection. Nature. 1987 Dec 10;330(6148):587–588. doi: 10.1038/330587a0. [DOI] [PubMed] [Google Scholar]
  7. Cohrs R. J., Goswami B. B., Sharma O. K. Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal. Biochemistry. 1988 May 3;27(9):3246–3252. doi: 10.1021/bi00409a019. [DOI] [PubMed] [Google Scholar]
  8. Cole J. L., Carroll S. S., Kuo L. C. Stoichiometry of 2',5'-oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study. J Biol Chem. 1996 Feb 23;271(8):3979–3981. doi: 10.1074/jbc.271.8.3979. [DOI] [PubMed] [Google Scholar]
  9. Der S. D., Yang Y. L., Weissmann C., Williams B. R. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3279–3283. doi: 10.1073/pnas.94.7.3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dong B., Silverman R. H. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem. 1995 Feb 24;270(8):4133–4137. doi: 10.1074/jbc.270.8.4133. [DOI] [PubMed] [Google Scholar]
  11. Dong B., Silverman R. H. A bipartite model of 2-5A-dependent RNase L. J Biol Chem. 1997 Aug 29;272(35):22236–22242. doi: 10.1074/jbc.272.35.22236. [DOI] [PubMed] [Google Scholar]
  12. Dong B., Xu L., Zhou A., Hassel B. A., Lee X., Torrence P. F., Silverman R. H. Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem. 1994 May 13;269(19):14153–14158. [PubMed] [Google Scholar]
  13. Gangemi J. D., Lazdins J., Dietrich F. M., Matter A., Poncioni B., Hochkeppel H. K. Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid. J Interferon Res. 1989 Apr;9(2):227–237. doi: 10.1089/jir.1989.9.227. [DOI] [PubMed] [Google Scholar]
  14. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hassel B. A., Zhou A., Sotomayor C., Maran A., Silverman R. H. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 1993 Aug;12(8):3297–3304. doi: 10.1002/j.1460-2075.1993.tb05999.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Houge G., Robaye B., Eikhom T. S., Golstein J., Mellgren G., Gjertsen B. T., Lanotte M., Døskeland S. O. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol. 1995 Apr;15(4):2051–2062. doi: 10.1128/mcb.15.4.2051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hovanessian A. G., Brown R. E., Kerr I. M. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature. 1977 Aug 11;268(5620):537–540. doi: 10.1038/268537a0. [DOI] [PubMed] [Google Scholar]
  18. Hovanessian A. G., Wood J., Meurs E., Montagnier L. Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3261–3265. doi: 10.1073/pnas.76.7.3261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jacobsen H., Czarniecki C. W., Krause D., Friedman R. M., Silverman R. H. Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology. 1983 Mar;125(2):496–501. doi: 10.1016/0042-6822(83)90222-2. [DOI] [PubMed] [Google Scholar]
  20. Jacobson M. D., Burne J. F., Raff M. C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 1994 Apr 15;13(8):1899–1910. doi: 10.1002/j.1460-2075.1994.tb06459.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ju S. T., Panka D. J., Cui H., Ettinger R., el-Khatib M., Sherr D. H., Stanger B. Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995 Feb 2;373(6513):444–448. doi: 10.1038/373444a0. [DOI] [PubMed] [Google Scholar]
  22. Kerr I. M., Brown R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):256–260. doi: 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koopman G., Reutelingsperger C. P., Kuijten G. A., Keehnen R. M., Pals S. T., van Oers M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994 Sep 1;84(5):1415–1420. [PubMed] [Google Scholar]
  24. Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S., Flavell R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995 Mar 31;267(5206):2000–2003. doi: 10.1126/science.7535475. [DOI] [PubMed] [Google Scholar]
  25. Kuida K., Zheng T. S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R. A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 1996 Nov 28;384(6607):368–372. doi: 10.1038/384368a0. [DOI] [PubMed] [Google Scholar]
  26. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995 Feb 10;80(3):401–411. doi: 10.1016/0092-8674(95)90490-5. [DOI] [PubMed] [Google Scholar]
  27. Meurs E. F., Watanabe Y., Kadereit S., Barber G. N., Katze M. G., Chong K., Williams B. R., Hovanessian A. G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol. 1992 Oct;66(10):5805–5814. doi: 10.1128/jvi.66.10.5805-5814.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nagata S. Apoptosis by death factor. Cell. 1997 Feb 7;88(3):355–365. doi: 10.1016/s0092-8674(00)81874-7. [DOI] [PubMed] [Google Scholar]
  29. Nolan-Sorden N. L., Lesiak K., Bayard B., Torrence P. F., Silverman R. H. Photochemical crosslinking in oligonucleotide-protein complexes between a bromine-substituted 2-5A analog and 2-5A-dependent RNase by ultraviolet lamp or laser. Anal Biochem. 1990 Feb 1;184(2):298–304. doi: 10.1016/0003-2697(90)90684-2. [DOI] [PubMed] [Google Scholar]
  30. Pavlovic J., Staeheli P. The antiviral potentials of Mx proteins. J Interferon Res. 1991 Aug;11(4):215–219. doi: 10.1089/jir.1991.11.215. [DOI] [PubMed] [Google Scholar]
  31. Reid T. R., Hersh C. L., Kerr I. M., Stark G. R. Analysis of 2',5'-oligoadenylates in cells and tissues. Anal Biochem. 1984 Jan;136(1):136–141. doi: 10.1016/0003-2697(84)90315-4. [DOI] [PubMed] [Google Scholar]
  32. Rutherford M. N., Kumar A., Nissim A., Chebath J., Williams B. R. The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res. 1991 Apr 25;19(8):1917–1924. doi: 10.1093/nar/19.8.1917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rysiecki G., Gewert D. R., Williams B. R. Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res. 1989 Dec;9(6):649–657. doi: 10.1089/jir.1989.9.649. [DOI] [PubMed] [Google Scholar]
  34. Sangfelt O., Erickson S., Castro J., Heiden T., Einhorn S., Grandér D. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ. 1997 Mar;8(3):343–352. [PubMed] [Google Scholar]
  35. Schröder H. C., Ugarkovic D., Merz H., Kuchino Y., Okamoto T., Müller W. E. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene. FASEB J. 1990 Oct;4(13):3124–3130. doi: 10.1096/fasebj.4.13.1698680. [DOI] [PubMed] [Google Scholar]
  36. Silverman R. H., Skehel J. J., James T. C., Wreschner D. H., Kerr I. M. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol. 1983 Jun;46(3):1051–1055. doi: 10.1128/jvi.46.3.1051-1055.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Stark G. R., Dower W. J., Schimke R. T., Brown R. E., Kerr I. M. 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature. 1979 Mar 29;278(5703):471–473. doi: 10.1038/278471a0. [DOI] [PubMed] [Google Scholar]
  38. Tamura T., Ishihara M., Lamphier M. S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T. W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 1995 Aug 17;376(6541):596–599. doi: 10.1038/376596a0. [DOI] [PubMed] [Google Scholar]
  39. Vaux D. L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2239–2244. doi: 10.1073/pnas.93.6.2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Williams B. R., Golgher R. R., Brown R. E., Gilbert C. S., Kerr I. M. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature. 1979 Dec 6;282(5739):582–586. doi: 10.1038/282582a0. [DOI] [PubMed] [Google Scholar]
  41. Wreschner D. H., James T. C., Silverman R. H., Kerr I. M. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. Nucleic Acids Res. 1981 Apr 10;9(7):1571–1581. doi: 10.1093/nar/9.7.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yang Y. L., Reis L. F., Pavlovic J., Aguzzi A., Schäfer R., Kumar A., Williams B. R., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 1995 Dec 15;14(24):6095–6106. doi: 10.1002/j.1460-2075.1995.tb00300.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell. 1993 Mar 12;72(5):753–765. doi: 10.1016/0092-8674(93)90403-d. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES